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MTT assay is one of the most prevalent in vitro 
methods that has been used to test CM1 function 
by using 3-[4,5,dimethylthiazol-2-yl]-2,5diphenyl tetra- 
zolium bromide. In our study, we used the following 
mitogens; Concanavalin A as a mitogenic positive 
control, SZcomplex (Saddam College of medicine) and 
Pneumo-23 (Pasteur merieux connaught) vaccine as test 
substances, no mitogens as negative control. 
Our study has it’s own objectives for the application 
of MTI assay. The first objective was the evaluation of 
CM1 level in HNCA patients in comparison with HC 
group via the susceptibility of PBL to be stimulated by 
different mitogenic substances.The second objective was 
the evaluation of using SZcomplex and P-23 vaccine as 
a biological modifiers that could be used in the immune 
therapy of HNCA in particular and other cancers in 
general. 
It has been shown that all HNCA groups were 
immunosuppressed in comparison with HC subjects. 
Nasopharyngeal CA (NPC) patients have shown the 
lowest CM1 level, then CA larynx (CL) and finally hypo- 
pharyngeal CA patients (HPC). It is highly suggestive 
that immune suppression in NPC patients may be 
necessary to activate the latent phase of Epstein-Barr 
virus having said that 85% of NPC patients in Iraq 
caused by EBV which has been proved by another study 
that we conducted. 
The most important result of our study that it has 
been shown that both S2-complex and Pneumo-23 
vaccine were excellent immune-stimulatory agents in 
vitro, and they might be a powerful agents of the future 
immune-therapy against cancers in general and HNCA 
in particular. 
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An epidemiological case study has been conducted on 
142 different head and neck cancer (HNCA) patients in 
Iraqi population. Patients were examined at different 
stages of the disease, 8 different types of HNCA were 
covered by this study. But for statistical purposes we 
have taken only the 3 most common types of HNCA 
for conducting our comparative epidemiological study 
which were nasopharyngeal CA (NPC), CA larynx (CL), 
and hypopharyngeal CA (HPC). NPC group was our 
top interest due to the fact that it is largely caused by 
viral infection, Epstein Barr virus (EBV) in that EBV- 
caused NPC is not uncommon event in the middle east 
and this unique etiology makes NPC an interested group 
of HNCA. Epidemiological parameters taken were age, 
sex, histology of the disease, staging, smoking, alcohol 
intake. It has been found that each HNCA group has it’s 
own profile of risk factors, but some of risk factors were 
pan-affective for all HNCA groups. 
It has been shown that all HNCA patients of 
squamous cell carcinoma (SCC) except for NPC patients 
that have elicited a relatively large proportion of highly 
undifferentiated carcinoma, namely lymphoepithelioma 
(LE). The age of HNCA patients was ranging between 
16 to 74 years old and found that age in HNCA patients 
is not distinct for each type of HNCA and these differ- 
ences are due to chance factor. 
It has been shown that the sex ratio in HNCA patients 
is different from each other significantly (p<O.O05). In 
general male:female ratio was 2.6:1 and there was a 
clear male predominance in HNCA patients over 
females except in HPC patients. Also it was found that 
smoking is a very important risk factor for HNCA, 
especially for NPC group. Regarding alcohol intake it 
was found that HNCA patients in general not so largely 
affected by this factor except for NPC patients who 
have shown a great relation with the level of daily 
alcohol intake. Lastly, all HNCA groups have shown a 
good relation with the positive family history but this 
feature was poor in case of NPC patients which is 
may be due to fact that NPC is largely caused by 
environmental factors rather than inherited ones like 
EBV as viral etiological factor. 
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The antimicrobial activity of ertapenem, a new long- 
acting carbapenem which can be dosed once daily, 
was tested against aerobic gram negative bacilli isolated 
from blood stream infections (BSI) in 156 cancer patients 
during the years 2000 and 2001. The MICs were deter- 
mined by NCCLS approved microdilution methods. The 
bacteria tested included 44 Klebsiella spp., 42 Escherichia 
coli, 19 Pseudomonas aeruginosa, 18 Enterobacter spp., 9 
Acinetobacter baumannii, 8 Citrobacter freundii, 5 
Proteus mirabilis, 4 Serratia marcescens, 3 Stenotropho- 
monas maltophilia, 2 Salmonella spp., and 2 Pantoea 
agglomerans. 
Ertapenem inhibited 75%, 80% and 83% of all 
isolates at concentrations of 1 pg/ml, 2 pg/ml and 4 
kg/ml respectively (breakpoint for susceptibility 58 
kg/ml). Ertapenem exhibited good activity against 
Klebsiella (MICgo <0.0625), E. coli (MI&, ~0.0625) 
Enterobacter (MIC90 0.5), Citrobacter (MICgo 52 
kg/ml), Proteus (MIC9o 0.125) Serratia (MTC90 0.0625) 
